C85.2
Mediastinal (thymic) large B-cell lymphoma
Clinical Classification Guidelines
Medical Intelligence & Overview
Mediastinal (thymic) large B-cell lymphoma is a specific type of non-Hodgkin lymphoma that originates in the lymphatic tissue of the mediastinum, the central part of the chest cavity. This form of lymphoma primarily involves large B lymphocytes, a type of white blood cell essential for immune response. It is often classified under the broader category of mediastinal lymphomas and tends to affect young adults, although it can occur in individuals of any age. Understanding this condition involves exploring its causes, typical symptoms, diagnostic process, and available treatment options.
Causes & Symptoms
Clinical Causes: Genetic mutations affecting B cells Immunodeficiency conditions that impair immune surveillance Environmental exposures (less clearly established) Infectious agents have not been directly linked Family history of lymphomas may increase risk
Key Symptoms: Persistent or enlarging chest mass Shortness of breath or difficulty breathing Chest pain or discomfort Swelling of the face, neck, or upper limbs Unintentional weight loss Night sweats and fever Fatigue and general malaise
Diagnostic & Treatment
Diagnosis Path: Physical examinations to check for swelling or masses Imaging tests such as CT scans or PET scans to visualize the mediastinal area and identify abnormalities Biopsy procedures, often via mediastinoscopy or needle biopsy, to obtain tissue samples for histopathological analysis Immunohistochemistry and molecular testing to confirm B-cell lineage Blood tests to assess overall health and organ function
Treatment Protocols: Chemotherapy regimens, most often including drugs like R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone) Radiation therapy aimed at the mediastinal area to reduce tumor burden Targeted therapies, such as monoclonal antibodies, depending on the specific disease characteristics Stem cell transplantation in cases of relapse or refractory disease Supportive care to manage treatment side effects and maintain patient health
Clinical Advice & FAQs
Billing Guidance
Is C85.2 a billable ICD-10 code?
Yes, C85.2 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C85.2?
Clinical documentation must specify the nature of Mediastinal (thymic) large B-cell lymphoma and any associated comorbidities for accurate reporting.
Cite this Clinical Reference